Michael Blaese, National Institutes of Health, Bethesda, Maryland of Internal Medicine, New Haven. (Spon. by Michael R. Blaese) The effect of steroid compounds on the in vitro production of Further studies on the carriers of the Wiskott-Aldrich Syndrome immunoglobulins was evaluated in cultures of peripheral blood were performed. Three carriers (mothers) of this X-linked disorder mononuclear cells (PBMC) . In a reverse hemolytic plaque assay were found who were heterozygous for the A and B isoenzymes of the addition of 10-5 to 10-8 M hydrocortisone to adult PBMCts in glucose-6-phosphate dehydrogenase (G6PD). Major cell types of the absenoe of other stimulants or mitogens resulted in the their peripheral blood were purified; then the presence of the dramatic induction of immunoglobulin secreting cells (IgSC was not altered by either adherent cell depletion or irradiation. or after 6 months of therapy, candidal stomatitis recurred.
These results indicate that the progenitor cells of T-lymphocyte Since treatment of CMC patients with ketoconazole improved colonies in cord blood have distinct biologic characteristics the responsiveness of lymphocytes to antigenic stimulation withwhen compared to colony progenitors present in normal adult blood out removing the serum inhibitory capacity, these 2 mechanisms This assay may prove to be useful in our efforts to understand may be dissociated. Infection-independent and infectionthe differentiation of T-cell function in man. dependent mechanisms appear to be involved; however, a direct role of ketoconazole on the immune system cannot be excluded.
TREATMENT OF MURINE AND HUMAN BONE MARROW WITH MONO-PLASMAPHERESIS IN ADOLESCENT MIXED CONNECTIVE TISSUE CLONAL ANTIBODIES TO T LYMPHOCYTES TO PREVENT GRAFT DISEASE(MCTD).
Alex Hertzman, Gilberto E. Rodri uez, antibody to murine T lymphocytes and complement eliminated GVHD She had leukopenia, hypergammaglobulinemia, and elevated sedrate. in all of 50 recipients. Recipient mice developed normal hemato-SGOT was 155, and LDH 588 units. ANA was (+) at 116400 with a crits, adult hemoglobin electrophoretic patterns, and normal T speckled pattern. ENA was (+) at 1/10,240, but only to RPN cell function by three months. Human bone marrow cells treated fraction. C Q of 2.4% was normal, but Raji cell assay was stronwith a monoclonal antibody to mature T lymphocytes (OKT-3) and ly (+). ~n t i DNA studies were negative. EMG revealed inflammacomplement had no residual detectable T cells as determined by tory findingisbecame normal. On plasmapheresis q3w she has re-E-rosette formation (16% pretreatment; 0%, post-treatment) or by mained asymptomatic with normal lab titers. Her favorable indirect immunofluorescence(l7% pre; 0% post). The total number responses suggest a wider use for this novel treatment in MCTD of nucleated cells was reduced by 50% during treatment with no and other immune complex diseases of children. decrease in the frequency of hematopoietic precursors (BFU-E colonies). The use of monoclonal antibodies to remove mature T 1 m hocytes fr uman bone marrow may be an effective method to pfebent human EBHB.
VERSUS HOST DISEASE (GVHD)
.
